Personal information

United States

Activities

Employment (4)

2Seventy Bio: Cambridge, Massachusetts, US

2021-11-01 to present | Senior Scientist (Research)
Employment
Source: Self-asserted source
Michael Harris

Luye Pharma (China): Shanghai, CN

2020-05-23 to 2021-11-01 | Senior Scientist (Cell Therapy)
Employment
Source: Self-asserted source
Michael Harris

LUMICKS: Amsterdam, NL

2019-10-16 to 2020-05-20 | Application Scientist (Immunooncology)
Employment
Source: Self-asserted source
Michael Harris

Johns Hopkins University: Baltimore, MD, US

2018-05-13 to 2019-05-01 | Postdoc (Institute of NanoBioTechnology )
Employment
Source: Self-asserted source
Michael Harris

Education and qualifications (2)

University of Cambridge: Cambridge, Cambridgeshire, GB

2013-10-01 to 2017-10-31 | PhD Infection, Immunity & Inflammation (Department of Medicine)
Education
Source: Self-asserted source
Michael Harris

University of Manchester: Manchester, Greater Manchester, GB

2008-10-01 to 2012-06-01 | BSc Joint Hons., Genetics with a Modern Language (Faculty of Life Science)
Education
Source: Self-asserted source
Michael Harris

Professional activities (1)

American Society of Gene Therapy and Cell Therapy: Milwaukee, Wisconsin, US

2021-04 to 2022-04 | Associate
Membership
Source: Self-asserted source
Michael Harris

Funding (1)

4 (1+3) Year Wellcome Trust PhD in Infection & Immunity

Award
Wellcome Trust (London, GB)
Source: Self-asserted source
Michael Harris

Works (8)

FUSION PROTEINS FOR DEPHOSPHORYLATING PROTEINS THAT REGULATE T CELL ACTIVATION THROUGH THE TCR SIGNALING PATHWAY

2023-02-23 | Patent
URI:

lens.org/140-231-689-282-866

PAT:

WO 2023/023602 A1

Contributors: Harris Michael; Wang Ninghai; Zhou Li; Shi Feng
Source: Self-asserted source
Michael Harris via The Lens

ROR1 CAR OR ROR1 /CD19 DUAL CAR T CELLS FOR THE TREATMENT OF TUMORS

2023-02-23 | Patent
URI:

lens.org/025-022-024-920-130

PAT:

WO 2023/020423 A1

Contributors: Zong Mengqi; Jiao Jie; Feng Jianxia; Harris Michael James; Kai Xin; Zhou Li; Wang Ninghai; Wei Liangjun; Chen Hao; Wen Xian
Source: Self-asserted source
Michael Harris via The Lens

Generation of Allogeneic CAR T Cells through Specific Degradation of the T Cell Antigen Receptor by E3 Ubiquitin Ligase Fusion Proteins

ACS Synthetic Biology
2022-06-17 | Journal article
Part of ISSN: 2161-5063
Part of ISSN: 2161-5063
Contributors: Michael J. Harris; Hao Chen; Tianyu Cai; Yuting Yi; Qiaowen Deng; Yi Yao; Tianle Lan; Yanfeng Guo; Xiufang Xu; Xian Wen et al.
Source: Self-asserted source
Michael Harris

DOWNREGULATION OF MEMBRANE-BOUND PROTEINS BY RECEPTOR TAC TECHNOLOGY

2022-03-17 | Patent
URI:

lens.org/047-159-233-847-49X

PAT:

WO 2022/053036 A1

Contributors: Zhou Li; Shi Feng; Harris Michael
Source: Self-asserted source
Michael Harris via The Lens

Quantifying persistence in the T‐cell signaling network using an optically controllable antigen receptor

Molecular Systems Biology
2021-05 | Journal article
Contributors: Michael J Harris; Muna Fuyal; John R James
Source: check_circle
Crossref

Dissecting cellular mechanics: Implications for aging, cancer, and immunity

Seminars in Cell & Developmental Biology
2019-09 | Journal article
Part of ISSN: 1084-9521
Contributors: Michael J. Harris; Denis Wirtz; Pei-Hsun Wu
Source: Self-asserted source
Michael Harris

Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing

Cancer Cell
2017-03 | Journal article
Part of ISSN: 1535-6108
Contributors: Ji Li; Nicola J. Stagg; Jennifer Johnston; Michael J. Harris; Sam A. Menzies; Danielle DiCara; Vanessa Clark; Maria Hristopoulos; Ryan Cook; Dionysos Slaga et al.
Source: Self-asserted source
Michael Harris

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK

Journal of Cancer
2016 | Journal article
Part of ISSN: 1837-9664
Contributors: Christine Damm-Welk; Faraz Siddiqi; Matthias Fischer; Barbara Hero; Vignesh Narayanan; David Ross Camidge; Michael Harris; Amos Burke; Thomas Lehrnbecher; Karen Pulford et al.
Source: Self-asserted source
Michael Harris